144 related articles for article (PubMed ID: 1969854)
1. Analgesic, receptor binding, and peripheral opioid activities of synthetic dermorphin-dynorphin hybrid peptides.
Ho CL; Ko JL; Hwang LL; Wang KT
Int J Pept Protein Res; 1990 Feb; 35(2):99-104. PubMed ID: 1969854
[TBL] [Abstract][Full Text] [Related]
2. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
Ho CL; Li CH
Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
[TBL] [Abstract][Full Text] [Related]
3. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
4. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
Koike K; Takayanagi I; Hirakura Y; Matsueda R
Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
[TBL] [Abstract][Full Text] [Related]
5. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
6. Dermorphin interaction with peripheral opioid receptors.
Giagnoni G; Parolaro D; Casiraghi L; Crema G; Sala M; Andreis C; Gori E
Neuropeptides; 1984 Dec; 5(1-3):157-60. PubMed ID: 6099487
[TBL] [Abstract][Full Text] [Related]
7. Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion.
Lazarus LH; Guglietta A; Wilson WE; Irons BJ; de Castiglione R
J Biol Chem; 1989 Jan; 264(1):354-62. PubMed ID: 2562839
[TBL] [Abstract][Full Text] [Related]
8. The choice of opioid receptor subtype in isolated preparations by dynorphins.
Oka T; Aoki K; Kajiwara M
Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
[TBL] [Abstract][Full Text] [Related]
9. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.
Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the receptor binding profile of (3H)-dermorphin in the rat brain.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Int J Pept Protein Res; 1988 Dec; 32(6):506-11. PubMed ID: 2907751
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
Lemaire S; Turcotte A
Can J Physiol Pharmacol; 1986 Jun; 64(6):673-8. PubMed ID: 2875777
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor binding profile of selected dermorphin-like peptides.
Rossi AC; de Castiglione R; Perseo G
Peptides; 1986; 7(5):755-9. PubMed ID: 2879276
[TBL] [Abstract][Full Text] [Related]
13. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of dermorphin, and [dermorphin1-7]-beta c-endorphin in rat brain membranes.
Westphal M; Hammonds RG; Li CH
Peptides; 1985; 6(1):149-52. PubMed ID: 2986079
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues.
Yoshino H; Nakazawa T; Arakawa Y; Kaneko T; Tsuchiya Y; Matsunaga M; Araki S; Ikeda M; Yamatsu K; Tachibana S
J Med Chem; 1990 Jan; 33(1):206-12. PubMed ID: 1967312
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and opioid activity of novel tetrapeptides analogous to sequence (1-4) of dermorphin.
Naqvi T; Raghubir R; Haq W; Tripathi A; Patnaik GK; Mathur KB
Neuropeptides; 1998 Aug; 32(4):333-8. PubMed ID: 10102678
[TBL] [Abstract][Full Text] [Related]
18. Central pharmacological activities and opiate receptor binding studies of some dermorphin analogs.
Giagnoni G; Parolaro D; Crema G; Mennuni L; Brini A; Casiraghi L; Sala M; Gori E
Peptides; 1985; 6 Suppl 3():155-9. PubMed ID: 3008117
[TBL] [Abstract][Full Text] [Related]
19. Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.
Giuliani S; Lecci A; Tramontana M; Maggi CA
Br J Pharmacol; 1996 Nov; 119(5):985-9. PubMed ID: 8922749
[TBL] [Abstract][Full Text] [Related]
20. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
